+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurovascular Devices Market by Disease Pathology, Devices, End-User - Global Forecast 2025-2030- Product Image
Neurovascular Devices Market by Disease Pathology, Devices, End-User - Global Forecast 2025-2030- Product Image
Sale

Neurovascular Devices Market by Disease Pathology, Devices, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454977
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurovascular Devices Market grew from USD 3.21 billion in 2023 to USD 3.44 billion in 2024. It is expected to continue growing at a CAGR of 7.34%, reaching USD 5.28 billion by 2030.

The neurovascular devices market encompasses medical devices used for diagnosing and treating disorders of the brain's blood vessels, such as aneurysms, arteriovenous malformations, and strokes. These devices are crucial in the medical field, addressing the rising incidence of neurovascular diseases, driven by factors such as an aging population and unhealthy lifestyle choices leading to conditions like hypertension and obesity. Applications of these devices range from surgical interventions, such as thrombectomy and embolization, to non-invasive procedures facilitating precise diagnosis and treatment, making them indispensable in end uses across hospitals, specialty clinics, and ambulatory surgical centers.

Key growth influencers in the market include technological advancements in neurovascular interventions, increased healthcare spending, and a growing awareness of minimally invasive procedures' benefits. Emerging opportunities lie in developing advanced imaging techniques, enhancing the precision and safety of these devices. Furthermore, the market is likely to benefit from increased collaboration between medical device companies and research institutions, aiming to innovate and streamline treatment procedures. Recommendations for seizing these opportunities include investing in R&D to push the boundaries of current neurovascular technology and forming strategic partnerships to enhance distribution channels and market presence.

However, market growth is tempered by certain challenges, including stringent regulatory requirements and high costs associated with advanced neurovascular procedures and devices, which can limit accessibility. Moreover, the evolving landscape of healthcare policies can pose additional hurdles. Ideal areas for innovation include developing cost-effective devices, integrating AI and machine learning for predictive analytics in patient care, and enhancing interoperability between various neurovascular systems. Business growth requires insight into the competitive dynamics characterized by strong rivalry among key players, necessitating differentiation through innovation and comprehensive market strategies. The market is complex and dynamic, with significant potential for those who can navigate its challenges effectively.

Understanding Market Dynamics in the Neurovascular Devices Market

The Neurovascular Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing incidences of a brain aneurysm and neurological disorders
    • Rising demand for minimally invasive procedures for brain surgeries
  • Market Restraints
    • High cost associated with the neurovascular interventions and devices
  • Market Opportunities
    • Emerging research activities and technological advancements in the field of neurovascular therapies
    • Ongoing product development and approvals of neurovascular devices
  • Market Challenges
    • Limited availability of neurosurgeons across the globe

Exploring Porter’s Five Forces for the Neurovascular Devices Market

Porter’s Five Forces framework further strengthens the insights of the Neurovascular Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Neurovascular Devices Market

External macro-environmental factors deeply influence the performance of the Neurovascular Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Neurovascular Devices Market

The Neurovascular Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Neurovascular Devices Market

The Neurovascular Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Neurovascular Devices Market

The Neurovascular Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, AngioDynamics Inc., Artio Medical, Inc., B. Braun Melsungen AG, BALT Group, Boston Scientific Corporation, Cerus Endovascular Inc., CONMED Corporation, Cook Medical Group, Endologix Inc., Evasc Medical Systems Corp., Integra Lifesciences Corporation, iVascular S.L.U., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medical Murray, Medtronic PLC, Microvention Inc., Penumbra, Inc., Phenox GmbH by Wallaby Medical, Rapid Medical Ltd., Scientia Vascular, Inc., Secant Group, LLC, Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zeus Company Inc..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Disease Pathology
    • Aneurysm
    • Arteriovenous Malformation & Fistulas
    • Ischemic Stroke
    • Stenosis
  • Devices
    • Cerebral Angioplasty & Stenting Systems
      • Embolic Coils
      • Flow Diverters
      • Liquid Embolic Agents
    • Cerebral Embolization & Aneurysm Coiling Devices
      • Carotid Artery Stents
      • Embolic Protection Systems
    • Neurothrombectomy Devices
      • Clot Retrieval Devices
      • Suction Devices
      • Vascular Snares
    • Support Devices
      • Micro Catheters
      • Micro Guidewires
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialized Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of a brain aneurysm and neurological disorders
5.1.1.2. Rising demand for minimally invasive procedures for brain surgeries
5.1.2. Restraints
5.1.2.1. High cost associated with the neurovascular interventions and devices
5.1.3. Opportunities
5.1.3.1. Emerging research activities and technological advancements in the field of neurovascular therapies
5.1.3.2. Ongoing product development and approvals of neurovascular devices
5.1.4. Challenges
5.1.4.1. Limited availability of neurosurgeons across the globe
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Neurovascular Devices Market, by Disease Pathology
6.1. Introduction
6.2. Aneurysm
6.3. Arteriovenous Malformation & Fistulas
6.4. Ischemic Stroke
6.5. Stenosis
7. Neurovascular Devices Market, by Devices
7.1. Introduction
7.2. Cerebral Angioplasty & Stenting Systems
7.2.1. Embolic Coils
7.2.2. Flow Diverters
7.2.3. Liquid Embolic Agents
7.3. Cerebral Embolization & Aneurysm Coiling Devices
7.3.1. Carotid Artery Stents
7.3.2. Embolic Protection Systems
7.4. Neurothrombectomy Devices
7.4.1. Clot Retrieval Devices
7.4.2. Suction Devices
7.4.3. Vascular Snares
7.5. Support Devices
7.5.1. Micro Catheters
7.5.2. Micro Guidewires
8. Neurovascular Devices Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialized Clinics
9. Americas Neurovascular Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Neurovascular Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Neurovascular Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NEUROVASCULAR DEVICES MARKET RESEARCH PROCESS
FIGURE 2. NEUROVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. NEUROVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NEUROVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NEUROVASCULAR DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 58. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 59. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 60. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 61. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 62. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 63. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 66. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 69. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 95. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 96. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 97. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 98. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 99. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 100. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 102. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 103. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 105. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 106. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 107. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 116. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 117. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 118. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 119. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 120. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 121. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 158. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 159. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 160. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 161. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 162. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 163. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 180. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 181. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 182. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 183. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 184. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 185. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 187. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 188. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 189. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 190. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 191. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 192. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 194. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 195. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 197. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 198. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 199. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 201. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 202. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 205. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 208. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 209. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 210. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 211. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 212. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 213. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 222. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 223. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 224. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 225. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 226. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 227. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 243. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 246. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 247. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 248. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 250. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 251. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 252. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 253. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 254. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 255. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 257. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 258. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 259. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 260. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 261. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 262. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 285. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 287. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 288. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 289. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 290. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 306. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 307. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 308. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 309. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECT

Companies Mentioned

The leading players in the Neurovascular Devices Market, which are profiled in this report, include:
  • Acandis GmbH
  • AngioDynamics Inc.
  • Artio Medical, Inc.
  • B. Braun Melsungen AG
  • BALT Group
  • Boston Scientific Corporation
  • Cerus Endovascular Inc.
  • CONMED Corporation
  • Cook Medical Group
  • Endologix Inc.
  • Evasc Medical Systems Corp.
  • Integra Lifesciences Corporation
  • iVascular S.L.U.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Medical Murray
  • Medtronic PLC
  • Microvention Inc.
  • Penumbra, Inc.
  • Phenox GmbH by Wallaby Medical
  • Rapid Medical Ltd.
  • Scientia Vascular, Inc.
  • Secant Group, LLC
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • Zeus Company Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.28 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report - Product Image

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Neurovascular Devices Market Report by Product, End User, and Region 2024-2032 - Product Image

Neurovascular Devices Market Report by Product, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Global Neurovascular Device Market - Product Image

Global Neurovascular Device Market

  • Report
  • 200 Pages
  • Global
From
Global Neurovascular Devices Market Analysis & Forecast to 2024-2034 - Product Image

Global Neurovascular Devices Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Neurovascular Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Therapeutic Application, End Users, Key Geographical Regions and Key Leading Players - Product Image

Neurovascular Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Therapeutic Application, End Users, Key Geographical Regions and Key Leading Players

  • Report
  • 255 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.